Impact of Hypertension on Cognitive Decline and Dementia

다국어 초록 (Multilingual Abstract)

Dementia reduces a person’s ability to perform their activities of daily living and is the leading cause of morbidity worldwide. While most preventive measures are ineffective in reducing dementia risk, active treatment of hypertension in middle-aged and older adults without dementia may reduce the incidence of dementia. Hypertension is associated with vascular dementia but may also affect the manifestations of Alzheimer disease. Observational studies support the association between hypertension and white matter lesions, hippocampal atrophy, and cognitive decline. Both increased and decreased blood pressure were related to the development of white matter lesions. Cohort studies showed that hypertension treatment and treatment duration were associated with lower cognitive decline. This study describes findings from randomized controlled studies on the effects of antihypertensives on cognitive decline. Only the Systolic Hypertension in Europe (Syst-Eur) trial using calcium-channel blockers demonstrated a significant reduction in dementia incidence. Further studies are required to evaluate the long-term benefits of antihypertensive treatment in dementia.

참고문헌 (Reference)

1 Barber R, "White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer’s disease, vascular dementia, and normal aging" 67 : 66-72, 1999

2 Breteler MM, "Vascular involvement in cognitive decline and dementia : epidemiologic evidence from the Rotterdam Study and the Rotterdam Scan Study" 903 : 457-465, 2000

3 Craft S, "The role of metabolic disorders in Alzheimer disease and vascular dementia : two roads converged" 66 : 300-305, 2009

4 Forette F, "The prevention of dementia with antihypertensive treatment : new evidence from the Systolic Hypertension in Europe(Syst-Eur)study" 162 : 2046-2052, 2002

5 Igase M, "The association between hypertension and dementia in the elderly" 2012 : 320648-, 2012

6 van Dijk EJ, "The association between blood pressure, hypertension, and cerebral white matter lesions: cardiovascular determinants of dementia study" 44 : 625-630, 2004

7 Lithell H, "The Study on Cognition and Prognosis in the Elderly(SCOPE) : principal results of a randomized double-blind intervention trial" 21 : 875-886, 2003

8 Meyer JS, "Risk factors for cerebral hypoperfusion, mild cognitive impairment, and dementia" 21 : 161-169, 2000

9 Peila R, "Reducing the risk of dementia : efficacy of long-term treatment of hypertension" 37 : 1165-1170, 2006

10 White WB, "Primary results of the intensive versus standard ambulatory blood pressure lowering to lessen functional decline in the elderly trial (INFINITY)"

11 Forette F, "Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe(Syst-Eur)trial" 352 : 1347-1351, 1998

12 Spence JD, "Preventing dementia by treating hypertension and preventing stroke" 44 : 20-21, 2004

13 Johnson KA, "Perfusion abnormalities in prodromal AD" 21 : 289-292, 2000

14 de la Torre JC, "Is Alzheimer’s disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics" 3 : 184-190, 2004

15 Zhao WQ, "Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer’s disease" 1792 : 482-496, 2009

16 Applegate WB, "Impact of the treatment of isolated systolic hypertension on behavioral variables. Results from the systolic hypertension in the elderly program" 154 : 2154-2160, 1994

17 Duron E, "Hypertension, cognitive decline and dementia" 101 : 181-189, 2008

18 Skoog I, "Hypertension and related factors in the etiology of Alzheimer’s disease" 977 : 29-36, 2002

19 Nagai M, "Hypertension and dementia" 23 : 116-124, 2010

20 Faraco G, "Hypertension : a harbinger of stroke and dementia" 62 : 810-817, 2013

21 World Health Organization, "Global action plan on the public health response to dementia 2017-2025" World Health Organization 2017

22 SPRINT MIND Investigators for the SPRINT Research Group, "Effect of intensive vs standard blood pressure control on probable dementia : a randomized clinical trial" 321 : 553-561, 2019

23 Livingston G, "Dementia prevention, intervention, and care" 390 : 2673-2734, 2017

24 Scheinberg P, "Dementia due to vascular disease : a multifactorial disorder" 19 : 1291-1299, 1988

25 Jimenez-Balado J, "Cognitive impact of cerebral small vessel disease changes in patients with hypertension" 73 : 342-349, 2019